The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1

Blood

Volumn 121, Issue 11, 2013, Pages 2154-2164

  Qin, Liuliang ^a   Zhao, Dezheng ^a   Xu, Jianfeng ^a   Ren, Xianghui ^a   Terwilliger, Ernest F ^a   Parangi, Sareh ^b   Lawler, Jack ^a   Dvorak, Harold F ^a   Zeng, Huiyan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; HISTAMINE; NUCLEAR RECEPTOR NUR77; SEROTONIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TR3; TRUNCATED HEMOGLOBIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION ASSAY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE SECTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; NUDE MOUSE; PHYSIOLOGY; PROTEIN PROCESSING; UPREGULATION;

ANIMALS; CAPILLARY PERMEABILITY; CELLS, CULTURED; FEMALE; HISTAMINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEROTONIN; THROMBOSPONDIN 1; UP-REGULATION;

MLCS; MLOWN;

EID: 84877613865     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-443903     Document Type: Article

References (43)

1. Azmitia EC. Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull. 2001; 56(5):413-424.
2. Beaven MA. Histamine: Its role in physiological and pathological processes. Monog Allergy. 1978; 13:1-113.
3. Faerber L, Drechsler S, Ladenburger S, et al. The neuronal 5-HT3 receptor network after 20 years of research-evolving concepts in management of pain and inflammation. Eur J Pharmacol. 2007; 560(1):1-8.
4. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88(3): 1183-1241.
5. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41-53.
6. Stark H. Histamine receptors. Biotrend reviews. 2007;1(11):1-8.
7. Brown NJ, Roberts LJ II. Histamine, bradykinin, and their antagonists. Vol, 10th ed. New York: McGraw Hill; 2001.
8. Nocito A, Dahm F, Jochum W, et al. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res. 2008;68(13):5152-5158.
9. Pelletier M, Siegel RM. Wishing away inflammation? New links between serotonin and TNF signaling. Mol Interv. 2009;9(6):299-301.
10. Cloëz-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: A perspective. J Leukoc Biol. 2007; 81(3):599-606.
11. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation. 1994;90(4):1919-1926.
12. McDuffie JE, Motley ED, Limbird LE, et al. 5- hydroxytryptamine stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures. J Cardiovasc Pharmacol. 2000;35(3):398-402.
13. Nishikawa T, Tsuno NH, Shuno Y, et al. Antiangiogenic effect of a selective 5-HT4 receptor agonist. J Surg Res. 2010;159(2):696-704.
14. Zauberman H, Michaelson IC, Bergmann F, et al. Stimulation of neovascularization of the cornea by biogenic amines. Exp Eye Res. 1969;8(1):77-83.
15. Norrby K. Evidence of a dual role of endogenous histamine in angiogenesis. Int J Exp Pathol. 1995; 76(2):87-92.
16. Norrby K. Mast cells and angiogenesis. APMIS. 2002;110(5):355-371.
17. Sörbo J, Jakobsson A, Norrby K. Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int J Exp Pathol. 1994;75(1):43-50.
18. Ghosh AK, Hirasawa N, Ohtsu H, et al. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med. 2002;195(8):973-982.
19. Schlüter T, Bohnensack R. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration. Biochem Pharmacol. 1999;57(10):1191-1197.
20. Jackson LN, Chen LA, Larson SD, et al. Development and characterization of a novel in vivo model of carcinoid syndrome. Clin Cancer Res. 2009;15(8):2747-2755.
21. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219(4587):983-985.
22. Nagy JA, Dvorak AM, Dvorak HF. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol. 2007;2:251-275.
23. Koch S, Tugues S, Li X, et al. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437(2):169-183.
24. Zeng H, Qin L, Zhao D, et al. Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med. 2006;203(3):719-729.
25. Zhao D, Qin L, Bourbon PM, et al. Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctions. Proc Natl Acad Sci USA. 2011;108(29): 12066-12071.
26. Lawler J, Sunday M, Thibert V, et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest. 1998;101(5):982-992.
27. Zhang X, Xu J, Lawler J, et al. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res. 2007;13(13):3968-3976.
28. Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem. 2001;276(29):26969-26979.
29. Hayashi K, Ohkura N, Miki K, et al. Early induction of the NGFI-B/Nur77 family genes in nephritis induced by anti-glomerular basement membrane antibody. Mol Cell Endocrinol. 1996;123(2): 205-209.
30. Lee SL, Wesselschmidt RL, Linette GP, et al. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science. 1995;269(5223):532-535.
31. Pettersson A, Nagy JA, Brown LF, et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest. 2000;80(1):99-115.
32. Zhang X, Kazerounian S, Duquette M, et al. Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J. 2009;23(10):3368-3376.
33. Alivisatos SGA, Bachrach WH, Beraldo WT, et al. Handbook of Experimental Pharmacology (XVIII/1). New York: Springer-Verlag New York Inc.; 1966.
34. Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr. 1980;110(5):851-858.
35. Shen BQ, Lee DY, Zioncheck TF. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem. 1999;274(46): 33057-33063.
36. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002;6(1):1-12.
37. http://, www.genomatix.de/cgi-bin/matinspector-prof/mat-fam.pl? s=58ca979d74b6b0826f55e75611310172.
38. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med. 1998;188(6):1135-1145.
39. Jakobsson AE. Angiogenesis induced by mast cell secretion in rat peritoneal connective tissue is a process of three phases. Microvasc Res. 1994; 47(2):252-269.
40. Cianchi F, Vinci MC, Masini E. Histamine in cancer: The dual faces of the coin. Cancer Biol Ther. 2008;7(1):36-37.
41. Dizeyi N, Bjartell A, Hedlund P, et al. Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. Eur Urol. 2005;47(6): 895-900.
42. Medina V, Croci M, Crescenti E, et al. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther. 2008;7(1):28-35.
43. Natori T, Sata M, Nagai R, et al. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomed Pharmacother. 2005;59(1-2):56-60.